 |
 |
 |
 |
 |
|
Chief |
Deputy Chief Kazushige Wakuda, M.D., Ph.D. |
Masashi Niwakawa,M.D., Ph.D. |
Shusuke Yoshikawa, M.D. |
Yuji Ishida, M.D. |
 |
 |
 |
 |
 |
|
Takeshi Aramaki, M.D. |
Yusuke Onozawa, |
Nahomi Tokudome, M.D., Ph.D. (Also Serving as Chief, Div. of Breast Oncology) |
Satoshi Hamauchi, M.D. |
Kentaro Yamazaki, M.D., Ph.D. |
 |
 |
 |
 |
 |
|
Tomoya Yokota, M.D., Ph.D. |
Junji Wasa, M.D., Ph.D. |
Munetaka Takekuma, M.D., Ph.D. |
Akiko Shibatani (Furusawa), M.D., Ph.D. |
Ryo Ko, M.D., Ph.D. (Also Serving as Senior Staff, Div. of Thoracic Oncology) |
This is a new clinical division launched in April, 2024. It specializes in early clinical development for anti-malignant tumor (anti-cancer) drugs. The phase I clinical trial is the very first step for a clinical development of a new anti-cancer drug. That’s when safety as well as efficacy of the drug are evaluated, and optimal dose and administration method are studied and discussed. At this early stage of the clinical development, the subject is often targeted to a wide range of malignant tumors, rather than a specific type of tumor or an organ, which makes it more sensible to have a cross-organ research system than otherwise. In addition, as a newly-developed anti-cancer drug may have an action mechanism different from conventional anti-cancer drugs, side effect management will also be beyond the scope of conventional ones. At the SCC, we have already had interprofessional collaborations among doctors and nurses at various clinical divisions, pharmacists, clinical test coordinators, etc. for the early clinical developments including the phase I clinical trials. Now that the Division of Advanced Medical Development has been established, a ward dedicated for the treatment management is prepared, the medical staff equipped with expertism and ample experiences in the field is stationed there, and the developments are being carried out much safer and faster than before.
In recent years, cancer genome profiling analysis has been clinically introduced, and new therapies focusing on specific gene abnormalities have been prominently developed ever since. At the same time, the number of therapies with the efficacies proven at the early stages of clinical developments has been increasing. This division works closely together with the Genomic Medicine Support Office to promote early clinical development of an effective new anti-cancer drug based on the results of cancer genome profiling analyses, aiming at the benefits of cancer patients by delivering it as fast as possible.
chemotherapy for lung cancer
clinical oncology
Certified Physician and Specialist, the Japanese Society of Internal Medicine
The Japanese Society of Medical Oncology
Specialist and Supervisory Doctor Certified by the Japanese Respiratory Society
The Japanese Cancer Association
The Japan Lung Cancer Society
The Japan Society of Clinical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The American Society of Clinical Oncology (ASCO)
respiratory medicine
Certified Physician and Specialist, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Respiratory Society
Specialist Certified by the Japan Society for Respiratory Endoscopy
The Japanese Society of Medical Oncology
The Japan Lung Cancer Society
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
diagnosis and treatment for malignant tumor in urological organs
The Japanese Society of Medical Oncology
malignant skin tumor
dermatologic surgery
drug therapy
Specialist Certified by the Japanese Dermatological Association
Supervisory Specialist of the Malignant Skin Tumor
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Commissioner, the Japanese Skin Cancer Society
The Japan Society of Clinical Oncology
The Japanese Society of Medical Oncology
The Japanese Association of Supportive Care in Cancer
pediatric cancer
support for cancer patient and his/her family
Specialist Certified by the Japan Pediatric Society
Hematologist Certified by the Japanese Society of Hematology
The Japanese Society of Pediatric Hematology/Oncology
The Japan Society for Neuro-Oncology
The Japanese Society for Transplantation and Cellular Therapy
International Member of the Children’s Oncology Group, U.S.A.
IVR procedures
Certified Radiologist and Supervisory Doctor, Representative, the Japanese Society of Interventional Radiology
Certified Radiologist, the Japan Radiological Society
Facilitator for the IVR Study Group in Central Japan, the Japanese Society of Interventional Radiology
Facilitator, the Palliative IVR Study Group
Representing Facilitator, the Shizuoka IVR Forum
Facilitator, the Japan Association for Percutaneous Trans-Esophageal Gastro-Tubing
Organizer, the Japanese Society of Implantable Port Assisted Treatment
Fellow, the Cardiovascular and Interventional Radiology Society of Europe
chemotherapy for gastroenterological cancer (i.e., gastrointestinal lymphoma, gastrointestinalstromal tumor (GIST))
chemotherapy for cancer in head and neck region
Certified Specialist for Cancer Chemotherapy and Supervisory Doctor for Specialist in Cancer Chemotherapy, Councilor, and Certified Interim Supervisory Doctor, the Japanese Society of Medical Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Certified Physician, Specialist and Supervisory Doctor, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Society of Gastroenterology
The Japan Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO)
The Japanese Society of Hematology
The Japan Society for Head and Neck Cancer
The Japan Society for Hematopoietic Cell Transplantation
The Japan Society of Transfusion Medicine and Cell Therapy
The Japan Gastroenterological Endoscopy Society
drug treatment for breast cancer, development of new drugs, cancer genome medicine, quality control of clinical studies, translational research
Certified Specialist for Cancer Drug Therapy and Supervisory Doctor, Councilor, the Japanese Society of Medical Oncology
Specialist Certified by the Japanese Breast Cancer Society
Registered Medical Practitioner Certified by the Japan Surgical Society
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Specialist for Mammography-interpretation at the Breast Cancer Screenings Certified by the Japan Central Organization on Quality Assurance of Breast Cancer Screening
The Japanese Society of Internal Medicine
The Japanese Society for Hereditary Tumors
The Japan Society of Clinical Oncology
chemotherapy for cancers in the head and neck region and the digestive system
Certified Physician, the Japanese Society of Internal Medicine
Specialist Certified by the Japanese Society of Gastroenterology
Cancer Chemotherapy Specialist Certified by the Japanese Society of Medical Oncology
chemotherapy for gastrointestinal cancer (colorectal cancer)
Certified Physician, the Japanese Society of Internal Medicine
The Japan Gastroenterological Endoscopy Society
The Japan Society of Clinical Oncology
The Japanese Society of Gastroenterology
The Japanese Society of Medical Oncology
The Japan Society of Coloproctology
The Japanese Association for Molecular Target Therapy of Cancer
The American Society of Clinical Oncology (ASCO）
The European Society for Clinical Oncology (ESMO）
chemotherapy for cancers in the head and neck region and the digestive system
molecular biology
Certified Physician, the Japanese Society of Internal Medicine
Cancer Chemotherapy Specialist and Supervisory Doctor Certified by the Japanese Society of Medical Oncology
The Japanese Cancer Association
The Japan Society for Head and Neck Cancer
The Japan Esophageal Society
The Japan Society of Clinical Oncology
The Japanese Society of Gastroenterology
The Japanese Association of Supportive Care in Cancer
The American Society of Clinical Oncology (ASCO)
The European Society for Medical Oncology (ESMO)
tumors in bones and soft tissues
Specialist and Oncologist for Bones and Soft Tissues Certified by the Japanese Orthopaedic Association
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Central Japan Association of Orthopaedic Surgery & Traumatology
The Japan Society of Clinical Oncology
The Japanese Cancer Association
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Commissioner, Councilor, Vice-Chairman of the Editorial Committee for Revising the Uterine Corpus Cancer Therapy Guidelines, Editorial Committee Member for Revising the Uterine Cervical Cancer Therapy Guidelines, Editorial Committee Member for Revising the Ovarian Cancer Therapy Guidelines, Working Group Member per Organ for the Particle-Beam Radiation Therapy Assessment, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
Cytodiagnosis Specialist and Commissioner for the Shizuoka Branch Office, the Japanese Society of Clinical Cytology
Working Group Member for Revising the Guidelines for Proper Use of G-CSF, the Japan Society of Clinical Oncology
Working Group Member for Revising the Cancer Immunotherapy Guidelines, the Japanese Society of Medical Oncology
The Japan Society of Gynecological and Obstetrical Surgery
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Educational Seminar Lecturer, the Japan Organization of Hereditary Breast and Ovarian Cancer (JOHBOC)
Commissioner, Chairman of the Cervical Cancer Committee, GICG Board Member, the Japanese Gynecologic Oncology Group (JGOG)
Representative Member of the Gynecological Oncology Group, Member for the International Testing Cooperation, the Japan Clinical Oncology Group (JCOG)
Researcher, the National Cancer Institute (USA)
Associate Editor, Gynecologic Oncology Research and Practice
Clinical Associate Professor, Hamamatsu University School of Medicine
gynecological oncology
Specialist and Supervisory Doctor Certified by the Japan Society of Obstetrics and Gynecology
Certified Specialist and Supervisory Doctor, Editorial Committee Member for Revising the Treatment Guidelines for Uterine Corpus Cancer, the Japan Society of Gynecologic Oncology
General Clinical Oncologist Certified by the Japanese Board of Cancer Therapy
The Japan Society of Clinical Oncology
The Japanese Cancer Association
The Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy
Specialist Certified by the Japanese Society for Hereditary Tumors
Committee Member for Uterine Cervical Cancer, Qualification Committee Member for Clinical Trial and Ethical Regulations, the Japanese Gynecologic Oncology Group (JGOG)
respiratory medicine
Certified Physician, the Japanese Society of Internal Medicine
The Japanese Respiratory Society
The Japan Lung Cancer Society
The Japanese Society of Medical Oncology
